Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Age Related Macular Degeneration Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Age Related Macular Degeneration 38
Jul 19, 2018: Allergan and Molecular Partners announce two positive phase 3 clinical trials for Abicipar pegol 8 and 12-week regimens for the treatment in patients with neovascular age-Related macular degeneration 38
Clinical Trial Profile Snapshots 39
Appendix 606
Abbreviations 606
Definitions 606
Research Methodology 607
Secondary Research 607
About GlobalData 607
Contact Us 608
Source 608

List of Tables
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2018* 7
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 17
Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 22
Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2018* 26
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 27
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2018* 29
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 32
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 34
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 36
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37

List of Figures
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16
Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 21
Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2018* 26
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 27
Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 32
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37
GlobalData Methodology 607

Companies Mentioned
- Novartis AG
- Bayer AG
- F. Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc
- Pfizer Inc
- Ophthotech Corp
- Allergan Plc
- Santen Pharmaceutical Co Ltd
- Novelion Therapeutics Inc
- Bausch Health Companies Inc